Abbvie Inc (ABBV): ABBV inks drug-discovery collaboration w...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	826
Posts	119574
Boards Moderated	14
Alias Born	09/05/2002

DewDiligence

Re: None

Thursday, 02/22/2024 10:38:17 AM

Thursday, February 22, 2024 10:38:17 AM

ABBV inks drug-discovery collaboration with (private) Tentarix:

https://finance.yahoo.com/news/abbvie-tentarix-announce-collaboration-develop-130500277.html

AbbVie and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology. The collaboration will integrate AbbVie's expertise in oncology and immunology with Tentarix's proprietary Tentacles™ platform.

Tentacles™ are multi-functional, conditionally-active antibody-based biologics that are designed specifically to activate immune cells that can modulate disease pathways, while potentially mitigating safety concerns associated with non-specific targeting of other immune cells.

How are “tentacles” different from ADCs?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”